Fluorescent Imaging as a Component of Diagnosing Pyoderma Gangrenosum: A Case Report
1Brett G. MacLeod, BS; 1Carissa S. Klarich, BA; 2Laurel L. Wessman, MD; 2Kevin J. Gaddis, MD; 2Nikifor K. Konstantinov, MD; 3Angie Wubben, BSN, RN, CWOCN; 3M. Mark Melin, MD, FACS, RPVI, FACCWS
1University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, United States 2University of Minnesota, Department of Dermatology, Minneapolis 3M Health Fairview Wound Healing Institute, Edina, Minnesota
Advances in Skin & Wound Care, May 2022
Related Publications
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
Detection of Bacterial Burden
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2024
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.